These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6613024)

  • 1. [Results of a long-term study of HBsAg in the blood in chronic liver disease].
    Stránský J; Helm R; Hrbác I; Sprincl L; Benda R
    Vnitr Lek; 1983 Jul; 29(6):565-70. PubMed ID: 6613024
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphological demonstration of hepatitis B virus surface antigen in liver cirrhosis, fibrosis and hepatocellular carcinoma (author's transl)].
    Chlumská A; Kautzner J
    Cas Lek Cesk; 1981 Jun; 120(23):689-92. PubMed ID: 6265089
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between viral hepatitis B and liver cirrhosis and carcinoma.
    Dong J; Zhou MH; Ye YL
    Chin Med J (Engl); 1980 Oct; 93(10):712-6. PubMed ID: 6778669
    [No Abstract]   [Full Text] [Related]  

  • 4. [Delta agent in a Chilean population HBsAg carrier].
    Velasco M; Brahm J; Ponzetto A
    Rev Med Chil; 1985 Jan; 113(1):3-5. PubMed ID: 4081382
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibodies against hepatitis B virus in chronic non-alcoholic HBsAg-negative hepatopathies].
    Moreira Vicente VF; Simón Marco MA; Pascasio Acevedo JM; Ruiz del Arbol Olmos L; Larraona Moreno JL; González Martín JA; Aguilera Musso D; Barcena Marugan R; Bueno Vallejo R
    Med Clin (Barc); 1984 Mar; 82(12):522-30. PubMed ID: 6738151
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
    Stránský J; Zichová M; Vodák M
    Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-1-Foeto protein (AFP) and hepatitis B surface antigen (HBsAg) in various hepatic disorders.
    Gupta SC; Satsangi JK; Mehrotra TN; Sinha SN
    J Assoc Physicians India; 1979 Jan; 27(1):1-6. PubMed ID: 92470
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B surface antigen and cirrhosis in hepatocellular carcinoma.
    Gahukamble LD; Sudarsanam D
    Indian J Cancer; 1982; 19(5):234-6. PubMed ID: 6299933
    [No Abstract]   [Full Text] [Related]  

  • 9. [Case-control study of hepatitis C HBs Ag and antivirus antibodies in chronic hepatopathies].
    Maiga MY; Dembele M; Maiga I; Sanago B; Sangare D; Traoré HA
    Sante; 2002; 12(4):389-92. PubMed ID: 12626293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphologic studies on the occurrence of HBs antigen in liver cirrhoses, epicirrhotic and pure cancers in a large autopsy sample].
    Riedel H; Hensel J; Justus J
    Dtsch Z Verdau Stoffwechselkr; 1983; 43(1):9-16. PubMed ID: 6840031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HB virus antigens in the liver during chronic hepatitis in children].
    Alvarez F; Bernard O; Alagille D
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():767-70. PubMed ID: 6762178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
    Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
    Seo JH; Park BC
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic histology in chronic liver disease in hepatitis B surface antigen positive cases.
    Ghosh AK; Dasgupta A; Raha K; Jana A; Majumdar DN
    J Indian Med Assoc; 1994 Oct; 92(10):333-5. PubMed ID: 7822848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidence of HBSAG carriers in chronic hepatitis and hepatic cirrhosis].
    Lungu I; Mardare G; Triandaf N; Zavate O; Ivan A; Bivol A
    Rev Med Chir Soc Med Nat Iasi; 1978; 82(2):215-8. PubMed ID: 705117
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
    Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
    J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HBsAG in the ascitic fluid in patients with liver cirrhosis (author's transl)].
    Chlumský J; Krtek V; Miksanová R
    Cas Lek Cesk; 1979 Aug; 118(34):1068-9. PubMed ID: 509462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.